National and Kapodistrian University of Athens
Πολυανθεκτικά εντεροβακτηριακά Gram-αρνητικά βακτηρίδια: παράγοντες κινδύνου ανάπτυξης νοσοκομειακής λοίμωξης και επίδραση στην έκβασή της: αναζήτηση της μοριακής βάσης της πολυαντοχής - ο ρόλος των integrons
Abstract
dc:descriptionObjectives Τhe objectives of this study were (i) to identify risk factorsassociated with the acquisition of multidrug-resistant Enterobacteriaceae isolatesresponsible for bloodstream infections (BSIs), (ii) to estimate the impact of multidrugresistanceon the outcome of such infections and (iii) to investigate the role ofintegrons in the multi-drug resistant phenotype in Enterobacteriaceae clinical isolates.Methods Risk factors for acquiring MDR Enterobacteriaceae BSIs wereassessed in a retrospective case-control study and those associated with mortality wereassessed by comparing survivors and nonsurvivors. The influence of multidrugresistance in hospital length of stay (LOS) in survivors was also evaluated. Themolecular basis of multidrug resistance and especially the role of integrons wasexamined by comparing the presence of ESBLs, VIM metallo-b-lactamases and class1 and 2 integrons in enterobacteriaceae isolates from patients of both groups and alsoin representative enterobacteriaceae isolates from colonizations. The genetic contentof integrons was determined with DNA sequencing.Results A total of 130 patients with Enterobacteriaceae BSIs were identifiedfrom whom 133 isolates were recovered. Sixty isolates from 57 patients (cases) werefound multidrug resistant (MDR) whereas 73 isolates from 73 patients (controls) wereinterpreted as non-MDR. Fifty-six Enterobacteriaceae BSIs were nosocomial, 16were health care associated and 58 were community acquired. Prior antibiotics useand a nosocomial setting were independently associated with BSI caused by MDR Enterobacteriaceae. Patients with MDR Enterobacteriaceae BSI had longer postBSI-onsetand total hospital stays (for survivors) than those with non-MDR infectionsbut no increased crude 30-day mortality rate. MDR Enterobacteriaceae clinicalisolates were more likely to harbor class 1 integrons (96,7% vs 17,8%, p<0,001) withbigger mean size (2.158±784bp vs 1.276±381,5bp p=0,001) or simultaneous presenceof more than one class 1 integron (28% vs 0%, p=0,056) in relation with non-MDREnterobacteriaceae. Among 56 nosocomial Enterobacteriaceae BSIs, integroncarryingmicroorganism was isolated in 50 (84,7%) in comparison with 9/58 (15.5%)of community-acquired BSIs (p<0,001). The mean size of class 1 integrons derivedfrom isolates causing nosocomial BSIs was bigger than that of integrons derived fromisolates from community-acquired BSIs (2.168,8±796,95 vs 1.233,3±413,11,p=0,008) but was not significant bigger than the size of integrons from isolatescausing health care associated BSIs (2.168,8±796,95 vs 1818,18±726,38, p=0,191).Finally, integron-carrying isolates, from both BSIs and colonizations, were foundmore often to be multidrug resistant (OR: 41,6, 95%CI: 16,7-103,2, p<0,001) or toproduce ESBLs (OR:10,98, 95%CI: 4,56-26,44, p<0,001) or metallo-β-lactamaseblaVIM (p<0,001) in comparison with integron-negative isolates.Conclusions: as independent risk factors for acquisition of BSI caused bymultidrug resistant Enterobacteriaceae isolate were found the prior exposure toantibiotics and the nosocomial origin of infection. Multidrug resistance of thecausative microorganisms was associated with elongated post-BSI and total LOS butno significant association was found with crude 30-day mortality. Finally, integronswere found to play a crucial role in the appearance of multidrug resistance bothdirectly and indirectly in this clinical isolates collection.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tryfinopoulou, Kyriaki
- Τρυφινοπούλου, Κυριακή
Subjects
dc:subject × 22- Πολυαντοχή στα αντιβιοτικά
- Εντεροβακτηριακά
- Παράγοντες κινδύνου λοίμωξης
- Έκβαση
- Ιντεγκρόνια τάξης 1 και 2
- Μεταλλοένζυμο vim
- Εκτεταμένου φάσματος β-λακταμάσες
- Πλασμιδιακή κεφαλοσπορινάση bla cmy
- Multidrug resistance
- Enterobacteriaceae
- Risk factors for infection
- Outcome
- Class 1 and 2 integrons
- Metalloenzyme bla VIM
- Extended spectrum β-lactamases
- Plasmid mediated Ampc - b - lactamase bla cmy
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Βασική Ιατρική
- Medical and Health Sciences
- Medical Biotechnology
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/37293